$0.40
(1.94%)
Add to watchlist
Create an alert
Stocks and Shares ISACareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
Company Information
About this company
Key people
John W. Hanna
President, Chief Executive Officer, Director
Nathan Smith
Chief Financial Officer
Keith Kennedy
Chief Operating Officer
Jeffrey Adam Novack
General Counsel, Secretary
Jennifer Foley
Chief Product Officer
Jessica Meng
Chief Commercial Officer
Michael D. Goldberg
Independent Chairman of the Board
Suresh Gunasekaran
Director
George W. Bickerstaff
Independent Director
Frederick E. Cohen
Independent Director
Christine M. Cournoyer
Independent Director
Click to see more
Key facts
- Shares in issue51.43m
- EPICCDNA
- ISINUS14167L1035
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- Market cap$1.05bn
- Employees644
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.